Related Experiment Video
Updated: Jun 11, 2026
04:24
Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
Published on: September 5, 2025
Fatigue in Parkinson's disease: a short update
1Department of Neurology, Akershus University Hospital, Lørenskog, Norway. antonie.beiske@ahus.no
Acta Neurologica Scandinavica. Supplementum
|July 1, 2010
Summary
Parkinson's disease (PD) fatigue is common, affecting 37-56% of patients. Understanding its varied definitions, measurements, and pathophysiology is crucial for developing effective treatments for this debilitating symptom.
Area of Science:
- Neurology
- Medical Research
- Clinical Practice
Background:
- Fatigue is a prevalent and complex symptom in Parkinson's disease (PD).
- There is a lack of universally accepted definitions and measurement tools for fatigue in PD.
- Existing research presents a wide range in reported fatigue prevalence (37-56%) due to methodological variations.
Purpose of the Study:
- To provide an update on the current understanding of fatigue in Parkinson's disease.
- To discuss various aspects of fatigue, including physical, mental, and chronic fatigue.
- To highlight challenges in fatigue assessment and the need for improved understanding of its pathophysiology.
Main Methods:
- Review of existing literature on fatigue in Parkinson's disease.
- Discussion of different fatigue assessment tools, including uni- and multidimensional self-report questionnaires.
- Analysis of factors associated with fatigue, its prevalence, and underlying pathophysiology.
Main Results:
- Fatigue in PD encompasses physical, mental, and chronic dimensions.
- Varied definitions and assessment methods complicate direct comparisons across studies.
- Prevalence estimates for fatigue in PD range significantly from 37% to 56%.
Conclusions:
- Standardized definitions and validated measurement tools are essential for accurate fatigue assessment in PD.
- Further research into the pathophysiology of subjective fatigue is required.
- Effective therapeutic strategies for PD-related fatigue are hindered by the current lack of understanding.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:21Fatigue
Fatigue occurs when materials rupture under repeated or fluctuating loads, even at stress levels far below their static breaking strength. It typically results in brittle failure, even for ductile materials. It is a critical consideration in designing machines and structural components subjected to repetitive or varying loads. The nature of these loadings can range from fluctuating loads like unbalanced pump impellers causing vibrations to repeatedly bending a thin steel rod wire back and forth...